期刊
MATERIALS TODAY
卷 26, 期 -, 页码 40-66出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.mattod.2018.12.003
关键词
-
资金
- National Natural Science Foundation of China [81872807, 51733001]
- Fundamental Research Funds for the Central Universities [2018XZZX001-14, XK1802-2]
- Thousand Talents Plan
Clustered regularly interspaced short palindromic repeat (CRISPR)/associated protein (CRISPR/Cas) system is an adaptable immune mechanism used by many bacteria to protect themselves from invading nucleic acids, and it has been recently exploited as an efficient tool for site-specific, programmable genome editing in both single cells and whole organisms with a precise manner. CRISPR/Cas system has been shown its great potentials for a wide range of biomedical applications, such as transcriptional control, epigenetic modification, genome-wide screening and chromosomal imaging, and treatment of genetic disorders. Despite these excitements, the shortage of delivery materials that can deliver genome editing tools (including plasmid DNA, mRNA, and ribonucleoprotein) represents one of the major challenges for successful CRISPR/Cas-based genome editing. This review seeks to provide a comprehensive overview of different types of carriers ranging from classic drug delivery materials to advanced drug delivery systems that can transport CRISPR/Cas systems and mediate genome editing at the targeted loci. The challenges and future prospects of the delivery materials for optimizing the CRISPR delivery system for clinical translations are also highlighted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据